<DOC>
	<DOC>NCT00213577</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750 versus 500 units) of the Dysport type A botulinic toxin for patient suffering from neurogenic urinary incontinence by an overactive bladder and the failure of anticholinergic drugs.</brief_summary>
	<brief_title>NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Neurogenic urinary incontinence with urodynamic overactivity resistant to anticholinergic Pregnancy Bladder cancer Symptomatic urinary infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>overactive neurogenic bladder</keyword>
</DOC>